Article info
PDFReview
EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples
- Correspondence to Dr Gillian Ellison, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK; gillian.ellison{at}astrazeneca.com
Citation
EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples
Publication history
- Received September 10, 2012
- Revised October 19, 2012
- Accepted October 22, 2012
- First published November 21, 2012.
Online issue publication
August 11, 2020
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/3.0/ and http://creativecommons.org/licenses/by-nc/3.0/legalcode